Different Lung Ultrasound Imaging Protocols in COVID-19 Pneumonia
Comparison of Two Different Lung Ultrasound Imaging Protocols in COVID -19 Pneumonia
1 other identifier
interventional
59
1 country
1
Brief Summary
Lung ultrasonography (LUS) is also used in COVID 19 pneumonia for diagnostic and follow-up purposes.It has been demonstrated in different studies that it can be used for pathologies in pleural and lung tissue. LUS was applied by different researchers by dividing the lungs into 12 and 14 regions and the results were shared.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 5, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 5, 2021
CompletedFirst Submitted
Initial submission to the registry
March 15, 2021
CompletedFirst Posted
Study publicly available on registry
March 18, 2021
CompletedMarch 18, 2021
March 1, 2021
2 months
March 15, 2021
March 17, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Correlation between Thoracic CT imaging results and LUS results
Lung ultrasonography will be performed within 6 hours of the Thoracic CT.
6 hours
Secondary Outcomes (1)
Characteristics of lesions
6 hours
Study Arms (2)
lung ultrasound 12
ACTIVE COMPARATOR12 zone lung ultrasonography protocol
lung ultrasound 14
ACTIVE COMPARATOR14 zone lung ultrasonography protocol
Interventions
Application of 12 areas (2 posterior, 2 lateral, and 2 anterior)lung ultrasonography protocol using the convex ultrasound probe (2-6 MHz)
Application of 14 areas (3 posterior, 2 lateral, and 2 anterior) lung ultrasonography protocol using the convex ultrasound probe (2-6 MHz)
Eligibility Criteria
You may qualify if:
- and 85 years old
- Hospitalized in intensive care unit
- PCR (polymerase chain reaction) tested
- Thoracic CT applied
You may not qualify if:
- Previous lung operation
- Thoracic wall disorder
- Interstitial lung disease
- Patients who did not consent to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Health Sciences, Bursa Yuksek Ihtisas Training and Research Hospital
Bursa, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Masking Details
- The investigator was unaware of patient information such as medical history, PCR (polymerase chain reaction) test result, laboratory measurements, and CT scan results
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator ,Assoc. PhD. M.D.
Study Record Dates
First Submitted
March 15, 2021
First Posted
March 18, 2021
Study Start
January 1, 2021
Primary Completion
March 5, 2021
Study Completion
March 5, 2021
Last Updated
March 18, 2021
Record last verified: 2021-03
Data Sharing
- IPD Sharing
- Will not share